Board Meetings for MANGALAM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| MANGALAM | Mangalam Drugs And Organics Limited | 12 Nov 2020 | Financial Results/Other business matters | To consider and approve the un-audited financial results for the period ended September 30, 2020 and other business matters. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 10 Aug 2020 | Financial Results/Other business matters | To consider and approve the Un-Audited financial results for the period ended Jun 30, 2020 and other business matters. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 29 Jun 2020 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2020 and other business matters. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 24 Jan 2020 | Financial Results | Pursuant to Regulation 29, 33 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, January 24, 2020 at the registered office of the Company at Mumbai, inter-alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended December 31, 2019. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 02 Nov 2019 | Financial Results | To consider and approve the Un-Audited financial results for the period ended September 30, 2019 and other business items. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 26 Jul 2019 | Financial Results | To consider and approve the un-audited financial results for the quarter ended Jun 30, 2019. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 09 May 2019 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2019 and other business matters | |
| MANGALAM | Mangalam Drugs And Organics Limited | 11 Feb 2019 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2018 and other business matters | |
| MANGALAM | Mangalam Drugs And Organics Limited | 14 Nov 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2018 and other business matters | |
| MANGALAM | Mangalam Drugs And Organics Limited | 14 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| MANGALAM | Mangalam Drugs And Organics Limited | 28 May 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2018 and other business matters | |
| MANGALAM | Mangalam Drugs And Organics Limited | 12 Feb 2018 | Results/Others | Inter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter & nine months ended December 31, 2017. 2. Any other matters with the permission of the chair. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 12 Dec 2017 | Dividend | inter-alia, to consider and declare the interim dividend for the financial year 2017-18. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 20 Nov 2017 | Results/Others | inter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter & half year ended September 30, 2017. 2. Any other matters with the permission of the chair. | |
| MANGALAM | Mangalam Drugs And Organics Limited | 11 Aug 2017 | Board Meeting Postponed | MANGALAM : 11-Aug-2017 : The Company had Informed the Exchange regarding the Board Meeting Scheduled to be held on August 04, 2017 inter-alia to consider and approve the following: (1) To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter ended June 30, 2017 2. Any other matters with the permission of the chair. the company has now inform the exchange that due to unavailability of the quorum the meeting of the Board of Directors is postponed and Rescheduled August 11, 2017. |